TITLE

Review: Somatostatin and its analogues do not reduce mortality in acute bleeding esophageal varices

AUTHOR(S)
Korula, Jacob
PUB. DATE
July 2005
SOURCE
ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p37
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents information on a study related to somatostatin, its analogues and whether it reduces mortality in acute bleeding esophageal varices. Randomized controlled trials compared somatostatin or its analogues with placebo or no treatment in patients with suspected or recently bleeding esophageal varices. Quality assessment of individual studies included allocation concealment and blinding. In patients with suspected acute bleeding from esophageal varices, somatostatin or its analogues do not reduce mortality. Patients who receive somatostatin require fewer units of blood products and have a lower failure rate of hemostasis.
ACCESSION #
18053699

 

Related Articles

  • Hemodynamic Effects of Terlipressin and High Somatostatin Dose during Acute Variceal Bleeding in Nonresponders to the Usual Somatostatin Dose. Villanueva, Càndid; Planella, Montserrat; Aracil, Carles; López-Balaguer, Josep M.; González, Begoña; Miñana, Josep; Balanz, Joaquim // American Journal of Gastroenterology;Mar2005, Vol. 100 Issue 3, p624 

    OBJECTIVES: High dose of somatostatin infusion achieves a greater reduction of hepatic venous pressure gradient (HVPG) than the usual dose, and terlipressin decreases HVPG through mechanisms other than somatostatin. Our aim was to assess the hemodynamic effects of terlipressin and high...

  • A Meta-analysis of Prophylactic Endoscopic Sclerotherapy for Esophageal Varices. Fardy, John M.; Laupacis, Andreas // American Journal of Gastroenterology;Nov1994, Vol. 89 Issue 11, p1938 

    Objectives: A number of randomized clinical trials of prophylactic sclerotherapy have been carried out with different results. The main objective of this study was to determine if the literature provides evidence that prophylactic sclerotherapy increases the survival rate of patients with...

  • Notice.  // American Journal of Gastroenterology;Jan1984, Vol. 79 Issue 1, p92 

    Reports that the Cleveland Variceal Hemorrhage Study Group is seeking patients who have bled from esophageal varices for entry into a randomized trial research, as of January 1984.

  • The Role of Sclerotherapy in the Treatment of Esophageal Varices: Personal Experience and a Review of Randomized Trials. Snady, H. // American Journal of Gastroenterology;Sep1987, Vol. 82 Issue 9, p813 

    Describes personal experience and discusses randomized trials regarding the role of sclerotherapy in the treatment of esophageal varices. Disadvantage of using portal-systemic shunt surgery for the treatment of variceal hemorrhage; Variables that may affect the success of endoscopic variceal...

  • Oral Pantoprazole for Erosive Esophagitis: A Placebo-Controlled, Randomized Clinical Trial. Richter, Joel E.; Bochenek, Wieslaw // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3071 

    OBJECTIVES: The aim of this dose-response study was to compare the effectiveness of 10 mg, 20 mg, and 40 mg of pantoprazole with that of placebo tablets in the healing and symptom relief of gastroesophageal reflux disease associated with erosive esophagitis, and to determine the optimal dose....

  • Dexlansoprazole shows benefits in healed erosive oesophagitis.  // PharmacoEconomics & Outcomes News;11/1/2008, Issue 565, p10 

    The article discusses a study presented during the 73rd Annual Scientific Meeting of the American College of Gastroenterology, on the use of dexlansoprazole on patients with healed erosive oesophagitis (EO). Clinical trials were conducted on 896 patients with healed EO, where dexlansoprazole was...

  • Prevention of Recurrent Variceal Bleeding-Is Surgical Rescue the Answer? Grace, Norman D. // Annals of Internal Medicine;2/15/90, Vol. 112 Issue 4, p242 

    Determines if surgical rescue is appropriate in preventing recurrent bleeding from esophageal varices. Therapies which help in decreasing the risk for recurrent variceal bleeding; Initial advantage for sclerotherapy; Factors to consider in choosing for the type of surgical rescue.

  • KLEBSIELLA PNEUMONIAE PANOPHTHALMITIS: A POSSIBLE COMPLICATION OF ENDOSCOPIC VARICEAL INJECTION SCLEROTHERAPY. Hung-Chang Hung; Wen-Chie Chen; Yee Chao; Ming-Chih Hou; Han-Chieh Lin; Full-Young Chang; Shou-Dong Lee // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2603 

    Complication of endoscopic variceal injection sclerotherapy for esophageal variceal hemorrhage is not unusual. However, sclerotherapy complicated panophthalmitis was never reported before. We report such an unusual complication and discuss its possible mechanism and treatment.

  • Prophylaxing Varices -- Time to Jump on the Band Wagon? Roy, H. K.; Thompson, Jon S. // American Journal of Gastroenterology;Oct1999, Vol. 94 Issue 10, p2811 

    Discusses research being done on endoscopic ligation and proparanolol for the prevention of variceal bleed. Reference to a study by S. K. Sarin, G. S. Lamba and M. Kumar published in the 1999 issue of the "New England Journal of Medicine"; Efficacy of endoscopic variceal ligation (EVL) in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics